SOX4 expression levels in urothelial bladder carcinoma
Yazarlar (5)
Prof. Dr. Sezgin Güneş Ondokuz Mayıs Üniversitesi, Türkiye
Doç. Dr. Zeynep YEĞİN Sinop Üniversitesi, Türkiye
Prof. Dr. Yurdanur Süllü Ondokuz Mayıs Üniversitesi, Türkiye
Recep Büyükalpelli
Ondokuz Mayıs Üniversitesi, Türkiye
Arş. Gör. Hasan Bağcı Ondokuz Mayıs Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Pathology Research and Practice (Q3)
Dergi ISSN 0344-0338 Dergi Bilgileri (2011)
Dergi Tarandığı Indeksler SCI
Makale Dili İngilizce Basım Tarihi 07-2011
Kabul Tarihi – Yayınlanma Tarihi 01-07-2011
Cilt / Sayı / Sayfa 207 / 7 / 423–427 DOI 10.1016/j.prp.2011.05.005
Makale Linki https://linkinghub.elsevier.com/retrieve/pii/S0344033811001191
UAK Araştırma Alanları
Tıbbi Biyoloji
Özet
High levels of SOX4 gene expression have been reported in a variety of human cancers. The protein may function in the apoptosis pathway, leading to cell death as well as to tumorigenesis. The aim of this study was to investigate the levels of SOX4 expression in bladder cancer. Urinary bladder tumor samples were obtained from 57 bladder cancer and 13 normal bladder biopsies. The levels of SOX4 expression in bladder cancer were determined by immunohistochemistry and real-time PCR. SOX4 gene expression was increased 2.2 times in bladder tumors as compared with normal tissue. The presence of protein was confirmed by immunostaining. There were significant differences between immunostaining of bladder tumors and normal bladder tissue (P = 0.001). The present data suggest that SOX4 gene may have a role in bladder cancer tumorigenesis.
Anahtar Kelimeler
Bladder carcinoma | Gene expression | SOX4 gene
Science Direct
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 21
Scopus 22
Google Scholar 30
SOX4 expression levels in urothelial bladder carcinoma